logo
Knoxvillian, former UT professor represented defendant in famous Scopes Monkey Trial

Knoxvillian, former UT professor represented defendant in famous Scopes Monkey Trial

Yahoo13-03-2025

The Scopes Trial that occurred 100 years ago was considered one of the more unusual in 20th-century America in attempting to delve into the debate of creationism versus evolution.
Also unusual was a Knoxville man involved in the trial. John Randolph Neal Jr. represented defendant John Scopes, the Rhea County instructor charged with teaching evolution, then a violation of a new state law.
While Neal was not as well-known as fellow defense team member Clarence Darrow or prosecution lead attorney and former presidential candidate William Jennings Bryan, he still stood out during that Dayton, Tennessee, trial and in his career. And it was not just for his praised legal skills, but also for his seemingly unkempt appearance and lax grading standards while he was earlier a University of Tennessee law instructor.
Born in Rhea County in 1876 as the son of Confederate Civil War veteran and Third District U.S. Congressman John Neal Sr., he had taught at the UT law school from 1909-23. While popular and respected among his students, his unorthodox mannerisms resulted in a clash with Dean Malcolm McDermott. This included accusations of not always showing up for class and talking more about current events than giving legal lessons.
As a result, he was one of several professors fired throughout campus by the UT Board of Trustees in 1923, despite his support among students. He had also been supportive of a fired psychology professor, Jesse Sprowls, who had taught evolution.
To him, as someone who deeply cherished American freedoms, the situation was more about man than monkeys. 'I don't care whether man descended from a monkey or whether the story of Genesis or evolution was true, to me it was a fight for the freedom of teaching,' he was quoted following his death as having said.
He apparently left UT amicably, but his inner anger over what he perceived as the world's wrongs remained and he would continue to fight them in legal circles.
The former UT undergraduate, who had gone to law school at Vanderbilt University and received his Ph.D. in history from Columbia, would go on to start his own law school named after his father. It was primarily for part-time and night students and thrived until about 1943, when a law was passed saying law schools had to be full-time colleges.
The former state senator – who in later years would often run unsuccessfully for the state's highest offices – was also known to support liberal and progressive causes. That included his strong advocacy for a public Tennessee Valley Authority to help the larger region instead of just private companies building power plants in places like North Alabama. He had also been involved in cases involving civil liberties and workers' rights.
When the Scopes Trial began, he had volunteered to lead the defense. He clashed with attorney Clarence Darrow, who later joined the team, over strategy. Noted reporter and writer H.L. Mencken, who covered the trial, did call Neal a brilliant attorney, however.
The July 1925 trial, which was held in a still-standing courthouse designed by Walter Chamberlin of Knoxville, had resulted in Scopes being found guilty, although the verdict was thrown out on a technicality regarding the fine. The Butler Act preventing the teaching of evolution was repealed in 1967.
Despite all his high-profile work and good mind in conversation throughout his life, Neal was always a study in contrasts. Besides his unusual dress and appearance habits, the lifelong bachelor preferred living in hotels. A check in some old city directories at the McClung Historical Collection in downtown shows him beginning before World War I as living in such places as the Stratford Hotel at 409 Wall and the Vendome at 417 W. Clinch Ave.
He later lived at the Oxford Hotel across Clinch Avenue and at the time of the trial lived at the Atkin Hotel at Gay Street and Depot Avenue. He later lived in the Watauga Hotel at 316 N. Gay St. before moving to the Spring City area beginning in the late 1940s. The Watauga building later had several floors taken down and became the site of Regas' restaurant for years.
His college at the time of the Scopes Trial was at the Union National Bank building at 302½ S. Gay St. before relocating to the Fretz Building, later called the McTownlee Building, at 603 Market St.
The UT law school during his time there was in now-razed Old College on the hill, then South Hall, and later Ayres Hall.
Neal lived in Spring City and attended Spring City Methodist Church for more than 10 years until his death from pneumonia in a Rockwood hospital on Nov. 23, 1959, at the age of 83. He was buried at Ault Cemetery in Roane County, with former law students among his pallbearers
Despite his sometimes-unkempt appearance, he tried during his lifetime to bring order to the legal issues regarding civil liberties for all.
For those wanting more information on Neal, Knoxville historian Jack Neely will be speaking on him and the trial at noon March 24 in Room 132 of the UT College of Law.
This article originally appeared on Knoxville News Sentinel: Knoxvillian represented defendant in famous Scopes Monkey Trial

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Menopause drug might prevent breast cancer and treat hot flashes, research finds
Menopause drug might prevent breast cancer and treat hot flashes, research finds

New York Post

time17 hours ago

  • New York Post

Menopause drug might prevent breast cancer and treat hot flashes, research finds

A drug intended to treat menopause symptoms could double as breast cancer prevention. New research from Northwestern University in Illinois found that Duavee, a Pfizer-made drug, 'significantly reduced' breast tissue cell growth, which is a major indicator of cancer progression. Advertisement A phase 2 clinical trial included 141 post-menopausal women who had been diagnosed with ductal carcinoma in situ (DCIS), also known as stage 0 breast cancer, according to a press release from Northwestern. This non-invasive breast cancer affects more than 60,000 American women each year, often leading to an outcome of invasive breast cancer. The women were separated into two groups — one received Duavee and the other took a placebo for a month before undergoing breast surgery. Duavee is a conjugated estrogen/bazedoxifene (CE/BZA) drug, which combines estrogen with another medication that minimizes the potential harmful side effects of the hormone. Advertisement 'The key takeaway from the study is that CE/BZA slows the growth (proliferation) of cells in milk ducts of DCIS that expressed the estrogen receptor significantly more than placebo,' Dr. Swati Kulkarni, lead investigator and professor of breast surgery at Northwestern University Feinberg School of Medicine, told Fox News Digital. 5 New research from Northwestern University found that the drug Duavee 'significantly reduced' breast tissue cell growth, a major indicator of cancer progression. Marko Geber – Another major finding is that the quality of life did not differ significantly between the two groups, but patients who took the CE/BZA reported fewer hot flashes during the study, she noted. 'This would be expected, as the drug is FDA-approved to treat hot flashes.' Advertisement Kulkarni presented the study last week at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. 5 The women in the study were separated into two groups — one received Duavee and the other took a placebo for a month before undergoing breast surgery. Gorodenkoff – 5 Those who took the drug reported fewer hot flashes during the study. fizkes – The findings are preliminary and have not yet been published in a medical journal. Advertisement 'What excites me most is that a medication designed to help women feel better during menopause may also reduce their risk of invasive breast cancer,' said the doctor, who is also a Northwestern Medicine breast surgeon. Women who face a higher risk of breast cancer — including those who have experienced 'high-risk lesions' — and who also have menopausal symptoms are most likely to benefit from the drug, according to Kulkarni. 'These women are typically advised against standard hormone therapies, leaving them with few menopausal treatment options,' the release stated. Study limitations The researchers said they are 'encouraged' by these early results, but more research is required before the medication can be considered for approval as a breast cancer prevention mechanism. 'Our findings suggest that CE/BZA may prevent breast cancer, but larger studies with several years of follow-up are needed before we would know this for sure,' Kulkarni told Fox News Digital. Dr. Sheheryar Kabraji, chief of breast medicine at the Roswell Park Comprehensive Cancer Center in Buffalo, New York, was not involved in the study but commented on the findings. 5 'What excites me most is that a medication designed to help women feel better during menopause may also reduce their risk of invasive breast cancer,' Dr. Swati Kulkarni said. sarayutsridee – Advertisement 'While intriguing, this study is highly preliminary, and more research will be needed before we can conclude that conjugated estrogen/bazedoxifene (CD/BZA), a form of the hormone estrogen commonly prescribed to address symptoms of menopause, prevents invasive breast cancer or is effective at reducing cancer risk,' he told Fox News Digital. Kabraji also noted that the study focused on reducing levels of one specific protein, 'which does not always predict reduced recurrence of breast cancer.' 'This study did not directly show that CE/BZA treatment reduces the risk of DCIS recurrence or development of invasive cancer,' he noted. 5 According to Kulkarni,'larger studies with several years of follow-up are needed' to confirm that the drug prevents breast cancer. Science RF – Advertisement 'Importantly, however, patients who received this therapy experienced no worsening of quality of life, and saw improvement in vasomotor symptoms, such as hot flashes. If found to be effective in preventing breast cancer, CE/BZA is likely to have fewer side effects than current medications used for breast cancer prevention.' Lead researcher Kulkarni emphasized that this medication is not for the treatment of invasive breast cancer or DCIS. 'Right now, we can say that women who are concerned about their risk of developing breast cancer can consider this medication to treat their menopausal symptoms,' she added.

Torah's clothing lessons backed by Yale study showing your attire changes how you think
Torah's clothing lessons backed by Yale study showing your attire changes how you think

Fox News

time18 hours ago

  • Fox News

Torah's clothing lessons backed by Yale study showing your attire changes how you think

It is in Genesis 27 that Isaac is preparing to pass the torch of Jewish leadership to his son, Esau — who, as the Torah makes clear, is entirely unfit for the role. His twin brother, Jacob, despite his shortcomings, is the one capable of carrying the mission forward. Rebecca, Isaac's wife and the mother of the twins, sees what's about to happen and intervenes. (See the video at the top of this article.) She tells Jacob to pose as Esau and receive the blessing in his place. Her key instruction? Put on Esau's best clothes. Isaac is blind — he won't see what Jacob is wearing. So why the costume? Because Rebecca understands something profound: To act like someone, you first have to feel like that person. And to feel like that person, you need to dress like that person. The strategy works. Jacob puts on the garments and receives the blessing. But the Torah isn't just telling a story; it's teaching a principle. It devotes entire chapters later to the clothing of the high priest — describing in detail the colors of the threads, the fabrics, the accessories, even the design of the undergarments. These aren't ritual decorations. They're instruments of transformation. The priest doesn't just look holy. By wearing sacred garments, he begins to feel holy — and that changes how he behaves. The Torah understood long before modern science that clothing shapes consciousness. Students in business suits negotiated far more successfully than those who were wearing casual clothes. In 2012, researchers at Northwestern conducted an experiment in which they gave participants a white coat. Some were told it was a painter's coat; others were told it was a doctor's coat. Those who believed they were wearing a doctor's coat performed significantly better on tasks requiring focus. In a similar experiment from Yale, students in business suits negotiated far more successfully than those who were wearing casual clothes. Sports fans know this. It's why football stadiums are full of grown men wearing the jerseys of their favorite player. Athletes understand this as well — they know the way they dress affects their performance. Psychologists now call this "enclothed cognition" — the idea that what we wear influences how we think, feel and perform. If you're depressed, you may naturally dress in a way that reflects your sadness — sweatpants and a baggy T-shirt. Psychologists have determined that this will only deepen the sadness. Professor Karen Pine suggests that a sad person should instead dress for happiness, with a well-cut dress made from natural fibers, colors that evoke nature, playful patterns that spark childhood memories — or even pair unexpected items, like a leather jacket over a dress, to engage the brain's craving for novelty. For more Lifestyle articles, visit Once again, God was right. Clothing isn't just about appearance or comfort. It's a tool for shaping who we are. When we dress with purpose, we prepare ourselves to live with purpose. Mark Gerson's new book is "God Was Right: How Modern Social Science Proves the Torah Is True," published by BenBella Books and distributed by Simon & Schuster (June 2025). This article is part of a series featured exclusively by Fox News Digital.

The great poaching: America's brain drain begins
The great poaching: America's brain drain begins

Axios

time21 hours ago

  • Axios

The great poaching: America's brain drain begins

The Trump administration's spending cuts and restrictions on foreign students are triggering a brain drain — and American scientists are panicking. Why it matters: U.S. researchers' fears are coming true. America's science pipeline is drying up, and countries like China are seizing the opportunity to surge ahead. 'This is such a race for being the science powerhouse that you never fully recover,' says Marcia McNutt, president of the National Academy of Sciences. 'You might accelerate back up to 60, but you can't make up for those years when you were at a standstill while the competition was racing ahead.' Driving the news: The National Science Foundation, which funds much of America's fundamental science research, is already doling out grants at its slowest pace in 35 years, The New York Times reports. More cuts to science could come with the "big, beautiful bill." Universities are also watching with bated breath as the administration tries to limit the number of foreign students studying in the U.S.. Harvard is pushing back, but could face a total ban on recruiting internationally. The Trump administration says it will " aggressively revoke" visas for Chinese students studying in "critical fields." By the numbers: While American universities are rescinding offers to incoming PhD students, other countries are recruiting heavily from U.S. labs. The journal Nature analyzed data from its jobs platform to track where scientists are looking for work. In the first few months of the Trump administration, there were jumps in the the number of U.S. applicants looking for jobs in Canada (+41%), Europe (+32%), China (+20%) and other Asian countries (+39%), compared to the same period in 2024. U.S. jobs saw fewer applications from candidates in Canada (–13%) and Europe (–41%). Case in point: France's Aix-Marseille University, which made headlines for earmarking millions of dollars for U.S. scientists, closed its application window after receiving a flood of apps. After American Nobel laureate Ardem Patapoutian's federal grant was frozen, he got an email from China offering 20 years of funding if he relocates his lab, The New York Times' Kate Zernike writes. He declined. 'This is a once-in-a-century brain gain opportunity,' the Australian Strategic Policy Institute wrote in a brief. The other side: The White House argues that its changes to the system will usher in a golden age of science and rebuild public trust. President Trump has also suggested that spots freed up by rejecting international students could be filled by American applicants. But professors say this isn't entirely realistic. "In hard sciences, in astronomy and physics and computer science, for example, there's no way you would fill that hole with local applicants of comparable quality," says Chris Impey, an astronomer at the University of Arizona. What to watch: 'The optimistic part of all of us thinks science is strong enough to outlast one administration, and for a while I thought that, but the hit to young people is at the center of the whole enterprise,' Impey says. 'It's like pulling the rug out from under the whole thing." It's not just brain drain of existing talent, he says. Students who are in high school and college now and thinking about a career in research might reconsider. "There's plenty of things smart kids can do. They don't have to go into science." At the same time, McNutt says she tells students: "If you went into graduate school in the fall of this year, by the time you get your PhD, this madness may be over. You come out with your new PhD ready to fill the gap."

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store